Literature DB >> 10481935

A case of classical xanthinuria (type 1) with diabetes mellitus and Hashimoto's thyroiditis.

Y Shibutani1, T Ueo, T Yamamoto, S Takahashi, Y Moriwaki, K Higashino.   

Abstract

In a 62-year-old woman with non-insulin-dependent diabetes mellitus and Hashimoto's thyroiditis, hypouricemia was detected by a routine examination. Her plasma uric acid level was markedly low and urinary excretion of uric acid was undetectable. The high plasma and urine levels of xanthine were observed, although those of hypoxanthine were within normal ranges at rest after an overnight fast. After taking diet, plasma concentration and urinary excretion of hypoxanthine were markedly increased together with those of xanthine. The xanthine oxidase activity of duodenal mucosa was below the limits of detection. Allopurinol was metabolized to oxypurinol and pyrazinamide to 5-hydroxypyrazinamide in spite of no activity of xanthine oxidase, suggesting that aldehyde oxidase converted allopurinol to oxypurinol and pyrazinamide to 5-hydroxypyrazinamide. Based on these findings, she was diagnosed as having a subtype of classical xanthinuria type 1 with the normal plasma concentration of hypoxanthine in fast.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481935     DOI: 10.1016/s0009-8981(99)00070-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

Review 1.  Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout.

Authors:  Lisa K Stamp; Tony R Merriman; Murray L Barclay; Jasvinder A Singh; Rebecca L Roberts; Daniel F B Wright; Nicola Dalbeth
Journal:  Semin Arthritis Rheum       Date:  2014-05-09       Impact factor: 5.532

Review 2.  Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.

Authors:  Slobodan P Rendić; Rachel D Crouch; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2022-06-01       Impact factor: 6.168

Review 3.  Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.

Authors:  Richard O Day; Garry G Graham; Mark Hicks; Andrew J McLachlan; Sophie L Stocker; Kenneth M Williams
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

4.  Protection against acetaminophen-induced liver injury by allopurinol is dependent on aldehyde oxidase-mediated liver preconditioning.

Authors:  C David Williams; Mitchell R McGill; Margitta Lebofsky; Mary Lynn Bajt; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-12-15       Impact factor: 4.219

5.  Xanthine dehydrogenase deficiency with novel sequence variations presenting as rheumatoid arthritis in a 78-year-old patient.

Authors:  Agnieszka Jurecka; Blanka Stiburkova; Jakub Krijt; Wanda Gradowska; Anna Tylki-Szymanska
Journal:  J Inherit Metab Dis       Date:  2010-01-14       Impact factor: 4.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.